Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Mouth Neoplasms × Epinephrine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pain, Postoperative 3 Breast Neoplasms 3 Pain 2 Uterine Cervical Dysplasia 1 Thyroid Neoplasms 1 Supratentorial Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Postoperative Hemorrhage 1 Nerve Block 1 Musculoskeletal Diseases 1 Mouth Neoplasms 1 Malignant Neoplasms of Male Genital Organs 1 Lung Neoplasms 1 Hypotension 1 Head and Neck Neoplasms 1 Goiter 1 Chronic Pain 1 Carcinoma, Renal Cell 1 Bowen's Disease 1 Agnosia 1 Acute Upper Gastrointestinal Bleeding 1 Acute Pain 1

Interventions

Cisplatin 15 Cetuximab 10 Radiotherapy 9 Biopsy 9 Magnetic Resonance Spectroscopy 8 pembrolizumab 7 Surveys and Questionnaires 7 Radiotherapy, Intensity-Modulated 7 Radiation 7 Carboplatin 7 Surgical Procedures, Operative 6 Specimen Handling 6 Fluorouracil 6 Celecoxib 6 X-Rays 5 Standard of Care 5 Paclitaxel 5 Observation 5 Drug Therapy 5 Sentinel Lymph Node Biopsy 4 Interviews as Topic 4 Chemoradiotherapy 4 Watchful Waiting 3 Ultrasonography 3 Taxes 3 Practice Guidelines as Topic 3 Positron Emission Tomography Computed Tomography 3 Platinum 3 Optical Imaging 3 Metformin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01418118 2011-08-16

Free4Flow

Oxford University Hospitals NHS Trust

Phase 4 Completed

Head and Neck Neoplasms, Hypotension, Mouth Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡